NFlection Therapeutics jobs and careers
Cambridge, MA, United States
As of October 23, 2026, NFlection Therapeutics has no open roles listed.
About NFlection Therapeutics
NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous. To address these rare disorders, which are also referred toas RASopathies because they are driven by the aberrant activation of the Ras/Raf/MEK/ERK pathway, NFlection develops first-in-class MEK (mitogen-activated protein kinase kinase) inhibitors as topical treatments.
Founded in 2014 by Mark De Souza and Mike Wootton.
- Founded
- 2014
- Employees
- 1 to 10
- Total funding
- $41.4M
- Headquarters
- Cambridge
Leadership
The top of NFlection Therapeutics's org chart, with how many people report into each leader.
William Hodder
Chief Executive Officer
4 reports
Guy Webster
Chief Medical Officer
2 reports
Diane Marcou
Consulting CFO
Jobs at NFlection Therapeutics
No open positions right now. Explore more companies on TheJobsMap.
NFlection Therapeutics jobs: common questions
- Is NFlection Therapeutics hiring right now?
- NFlection Therapeutics has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on NFlection Therapeutics's careers site.
- Where is NFlection Therapeutics headquartered?
- NFlection Therapeutics is headquartered in Cambridge, MA, United States and was founded in 2014.
- Who leads NFlection Therapeutics?
- William Hodder, Chief Executive Officer, is at the top of NFlection Therapeutics's org chart.
- How do I apply for a job at NFlection Therapeutics?
- Pick a role on NFlection Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on NFlection Therapeutics's own careers site, so you apply directly with the employer.